Kerbusch, T., Wählby, U., Milligan, P. A., & Karlsson, M. O. (2003). Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability. Blackwell Science Inc.
シカゴスタイル引用形Kerbusch, Thomas, Ulrika Wählby, Peter A. Milligan, , Mats O. Karlsson. Population Pharmacokinetic Modelling of Darifenacin and Its Hydroxylated Metabolite Using Pooled Data, Incorporating Saturable First-pass Metabolism, CYP2D6 Genotype and Formulation-dependent Bioavailability. Blackwell Science Inc, 2003.
MLA引用形式Kerbusch, Thomas, Ulrika Wählby, Peter A. Milligan, , Mats O. Karlsson. Population Pharmacokinetic Modelling of Darifenacin and Its Hydroxylated Metabolite Using Pooled Data, Incorporating Saturable First-pass Metabolism, CYP2D6 Genotype and Formulation-dependent Bioavailability. Blackwell Science Inc, 2003.